# Child Neurology * **Definition:** A medical specialty focused on the diagnosis and treatment of neurological disorders in infants, children, and adolescents, encompassing conditions such as epilepsy, cerebral palsy, and neurogenetic disorders. * **Taxonomy:** Specialties / Child Neurology ## News * Selected news on the topic of **Child Neurology**, for healthcare technology leaders * 2.4K news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 5/22/2025 | [**OSU Wexner gets $10M donation**](https://www.beckershospitalreview.com/capital/osu-wexner-gets-10m-donation/) | [[Beckers Hospital Review]] | | 5/20/2025 | [**Siddharth Srivastava - The Lancet Neurology**](https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00169-3/fulltext) | [[The Lancet]] | | 5/19/2025 | [**Arineta's SpotLight Duo CT Scanner Receives FDA Clearance for Low-Dose Lung Cancer Screening**](https://hitconsultant.net/2025/05/19/fda-clearance-enables-dual-heart-lung-screening-in-single-image/) | [[HIT Consultant]] | | 4/28/2025 | [**Baylor Genetics Joins Child Neurology Society as Official Genetic Testing Partner**](https://www.globenewswire.com/news-release/2025/04/28/3069345/0/en/Baylor-Genetics-Joins-Child-Neurology-Society-as-Official-Genetic-Testing-Partner.html) | [[Globe Newswire]] | | 3/12/2025 | [**Enhancing Palliative Care Education in Child Neurology Training**](https://www.physiciansweekly.com/enhancing-palliative-care-education-in-child-neurology-training/) | [[Physicians Weekly]] | | 12/16/2024 | [**Stanford Medicine names chief of child neurology**](https://www.beckershospitalreview.com/hospital-executive-moves/stanford-medicine-names-chief-of-child-neurology.html) | [[Beckers Hospital Review]] | | 12/13/2024 | [**Health care technology trends 2025: AI benefits, wearable use cases and telehealth expansion - AMA**](https://www.ama-assn.org/practice-management/digital/health-care-technology-trends-2025-ai-benefits-wearable-use-cases-and) | [[AMA]] | | 12/13/2024 | [**Inequitable rural health trends are alarming-and unacceptable**](https://www.ama-assn.org/delivering-care/population-care/inequitable-rural-health-trends-are-alarming-and-unacceptable) | [[AMA]] | | 12/5/2024 | [**FDA Grants Rare Pediatric Disease and Orphan Drug Designations to Nobias Therapeutics for Treatment of 22q11.2 Deletion Syndrome**](https://www.prweb.com/releases/fda-grants-rare-pediatric-disease-and-orphan-drug-designations-to-nobias-therapeutics-for-treatment-of-22q11-2-deletion-syndrome-302317611.html) | [[PRWeb]] | | 11/16/2024 | [**Bay Area News - Business Wire**](https://www.businesswire.com/portal/site/siliconvalley/template.PAGE/menuitem.cd1499e3c69468ef34735510e6908a0c/?javax.portlet.tpst=fb1c80c7240c38e114ab442bcf964fcd&javax.portlet.prp_fb1c80c7240c38e114ab442bcf964fcd_viewID=MY_PORTAL_VIEW&javax.portlet.prp_fb1c80c7240c38e114ab442bcf964fcd_ndmHsc=v2*A1731157200000*B1731793946000*DgroupByDate*G3*N1009940&javax.portlet.begCacheTok=com.vignette.cachetoken&javax.portlet.endCacheTok=com.vignette.cachetoken) | [[Business Wire]] | | 11/12/2024 | [**Digital health technologies play a transformative role in diabetes management and prevention**](https://www.news-medical.net/news/20241112/Digital-health-technologies-play-a-transformative-role-in-diabetes-management-and-prevention.aspx) | [[News Medical Net]] | | 11/1/2024 | [**Ferrum Health Raises $16M in Series A Funding to Unlock AI Adoption in Healthcare**](https://www.healthcareittoday.com/2024/11/01/ferrum-health-raises-16m-in-series-a-funding-to-unlock-ai-adoption-in-healthcare/) | [[Healthcare IT Today]] | | 10/29/2024 | [**Asia-Pacific Digital Diagnostics Market Analysis and Forecast, 2023-2024 & 2033: Synergetic Partnership Opportunities with Hospitals and Diagnostic Centers Fuel Opportunities - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241029232642/en/Asia-Pacific-Digital-Diagnostics-Market-Analysis-and-Forecast-2023-2024-2033-Synergetic-Partnership-Opportunities-with-Hospitals-and-Diagnostic-Centers-Fuel-Opportunities---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 10/8/2024 | [**Avania Buys Spanish MedTech CRO Anagram to Enhance Its Core CRO Offering in a New European Geography**](http://www.businesswire.com/news/home/20241008530546/en/Avania-Buys-Spanish-MedTech-CRO-Anagram-to-Enhance-Its-Core-CRO-Offering-in-a-New-European-Geography/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 9/23/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2823929) | [[JAMA Network]] | | 9/20/2024 | [**Ferrum Health Secures $16M for Vendor-Neutral AI Platform**](https://hitconsultant.net/2024/09/20/ferrum-health-secures-16m-for-vendor-neutral-ai-platform/) | [[HIT Consultant]] | | 9/20/2024 | [**Artificial Intelligence - Healthcare IT News**](https://www.healthcareitnews.com/taxonomy/term/7341/m89gsv6dzcjz.jsp/page/167?page=2) | [[Healthcare IT News]] | | 9/6/2024 | [**JuneBrain Receives MDIC Advanced Manufacturing Clearing House Award; Selects Compliance Group to Implement Siemens Polarion Design Quality System**](http://www.businesswire.com/news/home/20240906392607/en/JuneBrain-Receives-MDIC-Advanced-Manufacturing-Clearing-House-Award-Selects-Compliance-Group-to-Implement-Siemens-Polarion-Design-Quality-System/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 9/2/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2823031) | [[JAMA Network]] | | 8/26/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2822727) | [[JAMA Network]] | | 8/12/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2822114) | [[JAMA Network]] | | 8/12/2024 | [**Audio Highlights**](https://jamanetwork.com/journals/jama/fullarticle/2822137) | [[JAMA Network]] | | 7/23/2024 | [**Mirror, Mirror: How Digital Twins Can Rescue Healthcare - Medscape**](https://www.medscape.com/viewarticle/mirror-mirror-how-digital-twins-can-rescue-healthcare-2024a1000das) | [[Medscape]] | | 6/28/2024 | [**297+ telehealth companies to know - 2024 - Becker's Hospital Review**](https://www.beckershospitalreview.com/lists/297-telehealth-companies-to-know-2024.html) | [[Beckers Hospital Review]] | | 6/25/2024 | [**Research Antibodies and Reagents Market to be Worth $6.77 Billion by 2031 - Exclusive Report by Meticulous Research®**](https://www.prnewswire.com/news-releases/research-antibodies-and-reagents-market-to-be-worth-6-77-billion-by-2031---exclusive-report-by-meticulous-research-302181579.html) | [[PR Newswire]] | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **Child Neurology Society (CNS)**: A professional organization dedicated to the advancement of child neurology through education, research, and advocacy. - **American Academy of Pediatrics (AAP)**: A professional organization that provides guidelines and resources for pediatric care, including child neurology. - **Children's Medical Center Plano**: A Texas-based children's hospital that has expanded its facilities to enhance pediatric care, including neurology services. - **Dr. Shlomo Shinnar, MD, Ph.D.**: A leading authority in pediatric neurology specializing in epilepsy and child seizure disorders, recognized for significant contributions to treatment and education. - **National Institute of Neurological Disorders and Stroke (NINDS)**: A part of the NIH that funds research and provides information on neurological disorders affecting children. - **Dr. Martin L. Kutscher**: A pediatric neurologist with over 25 years of experience in diagnosing and treating neurobehavioral disorders such as ADHD and autism. He has authored several books and has been involved in educating parents and professionals. - **Neurogene Inc.**: A company focused on innovative gene therapy approaches for rare neurological diseases, including Rett syndrome. - **Cognitive Research Corporation (CRC)**: A clinical research organization expanding its leadership team with experts in neurology and psychiatry. - **Adrian L. Rabinowicz, MD**: Involved in the Stellina study, focusing on seizure clusters in young children, emphasizing the need for data on early childhood epilepsy. - **Children's National**: A pediatric healthcare organization that is enhancing its AI initiatives to improve children's health services. - **Dr. Dimitrios Arkilo**: New chief medical officer at Actio Biosciences, specializing in pediatric neurology and rare diseases, particularly childhood epilepsy. - **NeuroKaire**: A biotechnology company specializing in precision medicine for psychiatry and neurology, known for its pharmacogenetic testing. - **Altoida**: A company specializing in digital neurotechnology aimed at improving early detection and intervention for neurodegenerative disorders. - **Dr. Sunita Misra**: Vice President of Global Clinical Development at SK Life Science, leading studies on new treatments for CNS disorders. - **Aravindhan Veerapandiyan, MD**: Director of multiple neuromuscular programs at Arkansas Children's Hospital, involved in the development of Duchenne muscular dystrophy (DMD) therapies. - **Nihon Kohden**: A leading company in the field of medical devices, particularly known for its expertise in EEG technology and epilepsy diagnostics. - **Biogen**: A leading biotechnology company focused on pioneering innovative science to transform patients' lives, particularly in neurology. - **UCB**: A Belgium-based pharmaceutical company focusing on neurology and allergy treatments, recently divesting its mature neurology business in China. ### Partnerships and Collaborations - **Research collaborations**: Child neurology researchers often collaborate with universities and pharmaceutical companies to advance clinical trials for pediatric neurological disorders. - **CNS and AAP Collaboration**: Joint efforts to develop guidelines and educational resources for pediatric neurologists and general pediatricians. - **NINDS and Academic Institutions**: Collaborations to fund research projects focused on childhood neurological disorders. - **Collaboration between hospitals and tech companies**: Many child neurology departments are partnering with technology firms to develop telemedicine solutions and digital health tools to improve access to care. - **Neurelis, Inc.**: Engaged in clinical studies for VALTOCO, a treatment for seizure clusters in children, highlighting the importance of pediatric-focused research. - **DM Clinical Research**: Partnering with local physicians to establish a clinical site in Shreveport, focusing on neurology and pain management. - **SK Life Science and Dr. Sunita Misra**: Collaboration on clinical trials for adolescents with epilepsy. - **Altoida's Scientific Advisory Board**: Composed of experts in neuroscience and clinical neurology to enhance their Digital NeuroMarker Platform. - **PlatformQ Health**: Established the Medlive Advisory Board with experts in neurology to enhance medical education. - **Nobias Therapeutics**: Collaborating with pediatric medical centers to advance drug discovery for genetically-defined rare diseases. - **Children's National and Amazon Web Services**: A partnership to enhance AI initiatives in pediatric healthcare, supported by a $1 million funding boost. - **Nihon Kohden and Ad-Tech Medical**: A strategic acquisition aimed at improving comprehensive epilepsy care, particularly for drug-resistant cases. - **Zeto and Firefly Neuroscience**: Partnership to enhance distribution of EEG headsets and integrate analytics technology to improve neurological condition insights. - **Compliance Group and JuneBrain**: Partnering to implement a digital data-centric Design Quality System to support medical device startups. - **AIIMS Delhi and GE HealthCare**: Collaborating to develop healthcare AI solutions aimed at improving diagnostic capabilities. - **eVisit and UPMC**: Acquisition of tele-consult technology to enhance telehealth capabilities for health systems. ### Innovations, Trends, and Initiatives - **Telemedicine in Child Neurology**: Increasing use of telehealth services to provide remote consultations and follow-ups for pediatric patients with neurological conditions. - **Telehealth Expansion**: Increased demand for telehealth services post-pandemic, leading to broader access to child neurology care. - **Genetic Testing Advancements**: Emerging technologies in genetic testing to identify hereditary neurological disorders in children. - **Children's Medical Center Expansion**: The new patient tower incorporates advanced imaging technology and aims to enhance pediatric specialty care, including neurology. - **AI in Neurology**: Piramidal's AI model aims to streamline brain condition diagnostics, focusing initially on epilepsy. - **AI in Pediatric Healthcare**: Children's National is leveraging AI technology for newborn screening and improving healthcare delivery in resource-limited settings. - **Artificial Intelligence in Diagnostics**: Utilization of AI algorithms to assist in diagnosing conditions such as epilepsy and cerebral palsy in children. - **NGN-401 gene therapy**: Neurogene's clinical trial for Rett syndrome, showcasing innovative gene therapy approaches. - **NeuroKaire's Pharmacogenetic Assay**: A comprehensive test analyzing genetic variants to customize treatment plans for mental health and neurological disorders. - **Histotripsy Trial**: An innovative therapy using focused ultrasound for treating brain tumors, with potential implications for pediatric neurology. - **Actio Biosciences**: Advancing programs for Charcot-Marie-Tooth disease and genetic epilepsies, aiming to deliver innovative treatments. - **AAV Gene Therapy**: Advancements in adeno-associated virus gene therapy are targeting neurological disorders in children, offering new treatment options for conditions like spinal muscular atrophy. - **Wearable technology**: The use of wearable devices to monitor neurological symptoms in children is on the rise, providing real-time data to healthcare providers. - **Artificial Intelligence (AI)**: AI is being utilized to analyze patient data and assist in diagnosing neurological conditions more accurately and swiftly. - **Digital Diagnostics**: The digital diagnostics market is expanding, with a focus on quick and accurate solutions for pediatric conditions. - **Nobias Therapeutics**: Received FDA designations for their drug NB-001, aimed at treating neuropsychiatric symptoms in children with 22q11.2 deletion syndrome. - **Low-field MRI Technology**: Development of a simplified MRI system enhanced with machine learning for better access and cost-effective diagnostics in Alzheimer's disease. - **Swallow domain in Niemann-Pick disease**: Research indicating the swallow domain's relevance in clinical severity scales, enhancing patient outcome assessments. ### Challenges and Concerns - **Access to care**: Many families face challenges in accessing specialized child neurology care, particularly in underserved areas. - **Insurance Coverage**: Variability in insurance coverage for child neurology services, impacting access to necessary treatments. - **Access to Care**: There are ongoing concerns about equitable access to pediatric neurological care, particularly in rural and underserved areas. - **Equitable Access**: Need for equitable access to advanced neurological tools and treatments, especially for children. - **Clinical Trial Enrollment**: Challenges in enrolling pediatric patients with treatment-resistant epilepsy, particularly those aged 2-5 years, as highlighted in the Stellina study. - **Integration of technology**: There is a need for better integration of technology into existing healthcare systems to ensure seamless care for pediatric patients. - **Data privacy**: With the increase in digital health tools, concerns regarding the privacy and security of children's health data are paramount. - **Data Privacy**: Concerns regarding the handling of sensitive health information in telemedicine and electronic health records. - **Access to DMD therapies**: High costs and payer approval delays create significant barriers to treatment initiation, impacting patient outcomes. - **Data Privacy in AI**: Concerns regarding the security and scalability of AI solutions in healthcare, particularly in maintaining patient data privacy. - **Regulatory Landscape**: Navigating complex regulatory requirements for new digital therapeutics and medical devices remains a challenge for startups. - **Budget Constraints**: Financial limitations hindering the deployment of AI technologies in healthcare despite their potential benefits. - **Regulatory Acceptance of AI**: The FDA is challenged with balancing innovation and safety in the regulation of AI-driven clinical trials. - **Regulatory uncertainty**: Challenges faced by startups in navigating regulations while developing AI solutions for healthcare. - **Data privacy and security**: Concerns regarding data leakage and the need for a balance between innovation and patient privacy in healthcare technology. - **Regulatory Changes**: Concerns regarding the impact of the Supreme Court's decision to overturn the Chevron deference doctrine on healthcare regulations and programs. - **Market Pressures**: Pharmaceutical companies face increasing pressures to optimize operations and partner with local firms, particularly in China. ## Related Topics [[Neurology]]; [[Clinical Neurophysiology]]; [[Child Psychiatry]]